Patent 9597150 was granted and assigned to DUSA Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.
The invention encompasses a method of inhibiting the growth of hair in skin including epilation of follicles in the skin, waiting until within 5 days of the commencement of metanagen, applying a photodynamic agent to the skin, and exposing the skin to photoactivating light.